Clinical features of psoriatic arthritis.
Kishimoto M, Deshpande GA, Fukuoka K, Kawakami T, Ikegaya N, Kawashima S, Komagata Y, Kaname S.
Best Pract Res Clin Rheumatol. 2021 Jun;35(2):101670. doi: 10.1016/j.berh.2021.101670. Epub 2021 Mar 17.
Arthritis mutilans.
Haddad A, Chandran V.
Curr Rheumatol Rep. 2013 Apr;15(4):321. doi: 10.1007/s11926-013-0321-7.
Psoriatic arthritis mutilans.
Samanta J, Chattopadhyay A, Sharma A.
QJM. 2020 Oct 1;113(10):765-766. doi: 10.1093/qjmed/hcaa029.
Psoriatic arthritis.
Gladman DD, Brockbank J.
Expert Opin Investig Drugs. 2000 Jul;9(7):1511-22. doi: 10.1517/13543784.9.7.1511.
Psoriatic Arthritis Mutilans: Clinical and Radiographic Criteria. A Systematic Review.
Haddad A, Johnson SR, Somaily M, Fazelzad R, Kron AT, Chau C, Chandran V.
J Rheumatol. 2015 Aug;42(8):1432-8. doi: 10.3899/jrheum.141545. Epub 2015 Jun 15.
Juvenile psoriatic arthritis.
Ansell BM.
Baillieres Clin Rheumatol. 1994 May;8(2):317-32. doi: 10.1016/s0950-3579(94)80021-9.
Apremilast for the treatment of psoriatic arthritis.
Martin BC, Thomas LW, Dann FJ.
Dermatol Online J. 2017 Feb 15;23(2):13030/qt36n2k4jw.
Rare coding variants in NOX4 link high ROS levels to psoriatic arthritis mutilans.
Wang S, Nikamo P, Laasonen L, Gudbjornsson B, Ejstrup L, Iversen L, Lindqvist U, Alm JJ, Eisfeldt J, Zheng X, Catrina SB, Taylan F, Vaz R, Ståhle M, Tapia-Paez I.
EMBO Mol Med. 2024 Mar;16(3):596-615. doi: 10.1038/s44321-024-00035-z. Epub 2024 Feb 20.
Psoriatic arthritis mutilans: case series and literature review.
Bruzzese V, Marrese C, Ridola L, Zullo A.
J Rheumatol. 2013 Jul;40(7):1233-6. doi: 10.3899/jrheum.130093.
[Mutilans psoriatic arthritis].
Ribeiro A, Costa J, Bogas M, Costa L, Araújo D.
Acta Reumatol Port. 2009 Apr-Jun;34(2A):290-1.
